BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
See today's BioWorld
Home
» Other news to note for April 1, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for April 1, 2021
April 1, 2021
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abcellera, Agios, Aposense, Apotex, Arbutus, Basilea, Bioasis, Cello, Curza, Eloxx, Eurocine Vaccines, F-star, Frontier, FSD, Genix, Gilead, Iconovo, ISR, Journey Medical, Kahr, Karo, Lantern, Lilly, Merck & Co., Merck KGaA, Opiant, Pandion, Pharmacyte, PHT, Proteros, PTC, Recce, Roche, Servier, Teva, United Biomedical, United Neuroscience, Zikani.
BioWorld
Briefs
Other news to note
Coronavirus